Literature DB >> 11518023

Transport studies of insulin across rat jejunum in the presence of chicken and duck ovomucoids.

V Agarwal1, S Nazzal, I K Reddy, M A Khan.   

Abstract

Our aim was to evaluate the transport of insulin across rat jejunum in the presence of ovomucoids and to assess the effect of ovomucoids on intestinal tissue by studying the permeation of a lipophilic and a hydrophilic marker. Rat jejunal segments were mounted in a side-by-side diffusion chamber filled with Krebs bicarbonate buffer, bubbled with 95% O2/5% CO2 at a fixed flow rate and maintained at 37 degrees C. The permeation of insulin, a lipophilic marker ([7- 3H] testosterone) and a hydrophilic marker (D-[1- 14C] mannitol) was evaluated in the presence of 0.5-1.5 microM duck ovomucoid (DkOVM) or chicken ovomucoid (CkOVM). For stability and permeation of insulin in the presence of alpha-chymotrypsin, an enzyme-to-inhibitor ratio of 1:1 and 1:2 was used. In the absence of alpha-chymotrypsin, the permeability coefficient (Papp) of insulin at pH 7.4 was 0.922+/- 0.168 x 10(-7) cm s(-1), which decreased with increasing concentrations of DkOVM or CkOVM. Conversely, the permeation of the hydrophilic and lipophilic marker increased with increasing concentrations of CkOVM and DkOVM. In stability studies, the percentage of drug remaining was found to be 2-fold higher at the 1:2 ratio than with the 1:1 ratio of enzyme to inhibitor. This was in agreement with the 2-fold increase in flux values of insulin in the presence of alpha-chymotrypsin and DkOVM at the 1:2 ratio of enzyme to inhibitor. The decrease in permeation of insulin in ovomucoids was unexpected. Marker transport studies indicated that ovomucoids have the potential to modulate transcellular and paracellular permeability. The flux enhancement of insulin in the presence of alpha-chymotrypsin and DkOVM is encouraging. The use of ovomucoids offers potential to enhance oral delivery of insulin and warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518023     DOI: 10.1211/0022357011776522

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

Review 1.  Waiting to inhale: noninjectable insulin, are we there yet?

Authors:  Kjeld Hermansen
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

2.  Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: transport mechanism using Caco-2 cell monolayer.

Authors:  Rakhi B Shah; Mansoor A Khan
Journal:  AAPS J       Date:  2004-10-21       Impact factor: 4.009

Review 3.  Lessons learned from the clinical development of oral peptides.

Authors:  Morten Asser Karsdal; Bente Juul Riis; Nozer Mehta; William Stern; Ehud Arbit; Claus Christiansen; Kim Henriksen
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

4.  In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions.

Authors:  Ana L Martínez-López; Carlos J González-Navarro; Paula Aranaz; José L Vizmanos; Juan M Irache
Journal:  Acta Pharm Sin B       Date:  2021-03-01       Impact factor: 11.413

5.  Improving the stability of insulin in solutions containing intestinal proteases in vitro.

Authors:  Liefeng Zhang; Hui Jiang; Wenjie Zhu; Lin Wu; Lingling Song; Qiuyan Wu; Yong Ren
Journal:  Int J Mol Sci       Date:  2008-12-01       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.